These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8748613)

  • 41. Dopamine-dependent ectodomain shedding and release of epidermal growth factor in developing striatum: target-derived neurotrophic signaling (Part 2).
    Iwakura Y; Wang R; Abe Y; Piao YS; Shishido Y; Higashiyama S; Takei N; Nawa H
    J Neurochem; 2011 Jul; 118(1):57-68. PubMed ID: 21534959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors.
    Brooderson RJ; White FJ; Galloway MP
    Synapse; 1990; 6(4):395-7. PubMed ID: 2287994
    [No Abstract]   [Full Text] [Related]  

  • 43. Supersensitization of the oral response to SKF 38393 in neonatal 6-hydroxydopamine-lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment.
    Brus R; Kostrzewa RM; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1994 Jan; 268(1):231-7. PubMed ID: 8301563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits.
    Oh JD; Vaughan CL; Chase TN
    Brain Res; 1999 Mar; 821(2):433-42. PubMed ID: 10064831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons.
    Svenningsson P; Lindskog M; Rognoni F; Fredholm BB; Greengard P; Fisone G
    Neuroscience; 1998 May; 84(1):223-8. PubMed ID: 9522376
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vivo modulation of striatal phosphoproteins by dopaminergic agents.
    Di Luca M; Cimino M; Abbracchio MP; Cattabeni F
    Eur J Pharmacol; 1989 Oct; 172(4-5):321-8. PubMed ID: 2573537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.
    Aubert I; Guigoni C; Håkansson K; Li Q; Dovero S; Barthe N; Bioulac BH; Gross CE; Fisone G; Bloch B; Bezard E
    Ann Neurol; 2005 Jan; 57(1):17-26. PubMed ID: 15514976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tyrosine phosphorylation of NMDA receptor in rat striatum: effects of 6-OH-dopamine lesions.
    Menegoz M; Lau LF; Hervé D; Huganir RL; Girault JA
    Neuroreport; 1995 Dec; 7(1):125-8. PubMed ID: 8742433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenotypic disruption to orofacial movement topography in conditional mutants with generalized CamKIIa/Cre D1Tox versus striatal-specific DARPP-32/Cre D1Tox ablation of D1 dopamine receptor-expressing cells.
    Tomiyama K; Kim HA; Kinsella A; Ehrlich ME; Schütz G; Koshikawa N; Lawrence AJ; Waddington JL; Drago J
    Synapse; 2011 Sep; 65(9):835-42. PubMed ID: 21308794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynorphin modulates dopamine D1-receptor mediated turning behavior in 6-hydroxydopamine-lesioned rats.
    van de Witte SV; Groenewegen HJ; Drukarch B; Voorn P
    Neurosci Lett; 2000 Aug; 290(1):37-40. PubMed ID: 10925169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in the D1 receptor-adenylate cyclase complex after priming.
    Morelli M; De Montis G; Di Chiara G
    Eur J Pharmacol; 1990 May; 180(2-3):365-7. PubMed ID: 2114301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EEG modifications in the cortex and striatum after dopaminergic priming in the 6-hydroxydopamine rat model of Parkinson's disease.
    Vorobyov VV; Schibaev NV; Morelli M; Carta AR
    Brain Res; 2003 May; 972(1-2):177-85. PubMed ID: 12711091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism.
    Brown AM; Deutch AY; Colbran RJ
    Eur J Neurosci; 2005 Jul; 22(1):247-56. PubMed ID: 16029214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice.
    Mani SK; Fienberg AA; O'Callaghan JP; Snyder GL; Allen PB; Dash PK; Moore AN; Mitchell AJ; Bibb J; Greengard P; O'Malley BW
    Science; 2000 Feb; 287(5455):1053-6. PubMed ID: 10669419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat--relationship to circling behaviour.
    Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
    Biochem Pharmacol; 1995 May; 49(9):1185-93. PubMed ID: 7763300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of electroconvulsive shock on the phosphorylation of DARPP-32 in rat striatum.
    Park HJ; Cui FJ; Roh JW; Jung YC; Kim SH; Kim YS; Kang UG
    Psychiatry Res; 2009 Nov; 170(1):91-5. PubMed ID: 19818513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphorylation of DARPP-32 is regulated by GABA in rat striatum and substantia nigra.
    Snyder GL; Fisone G; Greengard P
    J Neurochem; 1994 Nov; 63(5):1766-71. PubMed ID: 7931332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylxanthines reverse the adipsic and aphagic syndrome induced by bilateral 6-hydroxydopamine lesions of the nigrostriatal pathway in rats.
    Casas M; Prat G; Robledo P; Barbanoj M; Kulisevsky J; Jané F
    Pharmacol Biochem Behav; 2000 Jun; 66(2):257-63. PubMed ID: 10880677
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopamine D1 vs D5 receptor-dependent induction of seizures in relation to DARPP-32, ERK1/2 and GluR1-AMPA signalling.
    O'Sullivan GJ; Dunleavy M; Hakansson K; Clementi M; Kinsella A; Croke DT; Drago J; Fienberg AA; Greengard P; Sibley DR; Fisone G; Henshall DC; Waddington JL
    Neuropharmacology; 2008 Jun; 54(7):1051-61. PubMed ID: 18367215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist.
    van de Witte SV; Drukarch B; Stoof JC; Voorn P
    Brain Res Mol Brain Res; 1998 Oct; 61(1-2):219-23. PubMed ID: 9795227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.